David van Klaveren
Erasmus Universiteit Rotterdam
H-index: 39
Europe-Netherlands
Top articles of David van Klaveren
Personalized decision-making for aneurysm treatment of aneurysmal subarachnoid hemorrhage: development and validation of a clinical prediction tool
BMC neurology
2024/2/15
Jordi De Winkel
H-Index: 0
Ruben Dammers
H-Index: 22
Mathieu Van Der Jagt
H-Index: 17
David Van Klaveren
H-Index: 24
Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement vs. primary suture only in midline laparotomies (PRIMA): long-term outcomes of a …
The Lancet Regional Health–Europe
2024/1/1
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an …
HPB
2020/1/1
Avoiding the pitfalls in developing and validating prediction models for rare outcomes in nested case-control
Cancer Research
2024/3/22
David Van Klaveren
H-Index: 24
Development and validation of a clinical prediction model to predict recurrence and disease-specific-mortality in patients with melanoma after sentinel lymph node biopsy
BMJ open
2022/7/1
Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group
JHEP Reports
2023/2/1
David Van Klaveren
H-Index: 24
Developing and Testing Models for COVID-19 Health Outcomes
2023/12/20
Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials
medRxiv
2023
David Van Klaveren
H-Index: 24
Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989–2019
Eclinicalmedicine
2023/6/1
David Van Klaveren
H-Index: 24
Otto Visser
H-Index: 6
Using Different Data Sets to Test How Well Clinical Prediction Models Work to Predict Patients' Risk of Heart Disease
2023/12/20
Jason Nelson
H-Index: 17
Gaurav Gulati
H-Index: 7
Ben Van Calster
H-Index: 44
David Van Klaveren
H-Index: 24
Can machine learning aid the selection of percutaneous vs surgical revascularization?
Journal of the American College of Cardiology
2023/11/28
Neil O'Leary
H-Index: 23
David Van Klaveren
H-Index: 24
Measuring the performance of prediction models to personalize treatment choice: Defining observed and predicted pairwise treatment effects
Statistics in medicine
2023/4/15
Integrated care in patients with atrial fibrillation-a predictive heterogeneous treatment effect analysis of the ALL-IN trial
Plos one
2023/10/19
US and Dutch perspectives on the use of COVID-19 clinical prediction models: findings from a qualitative analysis
Medical Decision Making
2023/5
David Van Klaveren
H-Index: 24
Jason Nelson
H-Index: 17
1120P Development and external validation of a clinical prediction model to predict recurrence-free survival and melanoma-specific survival in patients with melanoma after …
Annals of Oncology
2023/10/1
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model
EClinicalMedicine
2023/9/1
David Van Klaveren
H-Index: 24
P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+ 2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
HemaSphere
2023/8/1
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases
npj Digital Medicine
2023/3/30
David Van Klaveren
H-Index: 24
External validation of 18F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy
Nuclear Medicine Communications
2023/8/1
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches
BMC Medical Research Methodology
2023/3/28
David Van Klaveren
H-Index: 24
